ID   9L/lacZ
AC   CVCL_5656
SY   9L/LacZ
DR   CLO; CLO_0001541
DR   ATCC; CRL-2200
DR   BCRC; 60247
DR   BCRJ; 0029
DR   CCRID; 3101RATTCR13
DR   CLS; 305208
DR   Wikidata; Q54605952
RX   PubMed=1737331;
RX   PubMed=8416743;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS:0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=1737331;
RA   Lampson L.A., Wen P.Y.-C., Roman V.A., Morris J.H., Sarid J.A.;
RT   "Disseminating tumor cells and their interactions with leukocytes
RT   visualized in the brain.";
RL   Cancer Res. 52:1018-1025(1992).
//
RX   PubMed=8416743;
RA   Lampson L.A., Lampson M.A., Dunne A.D.;
RT   "Exploiting the lacZ reporter gene for quantitative analysis of
RT   disseminated tumor growth within the brain: use of the lacZ gene
RT   product as a tumor antigen, for evaluation of antigenic modulation,
RT   and to facilitate image analysis of tumor growth in situ.";
RL   Cancer Res. 53:176-182(1993).
//